Javascript must be enabled to continue!
Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
View through CrossRef
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial. We evaluated the effect of the involvement of urothelial bladder carcinoma (UBC) as a potential prognostic factor for overall survival (OS) and progression-free survival (PFS). The cohort included 115 patients with UTUC, subgrouped between January 2009 and December 2019 as follows: (1) only UTUC and (2) UTUC with synchronous or metachronous UBC (UTUC + UBC). Univariate and multivariate analyses were performed to identify independent prognostic factors for OS and PFS. Synchronous or metachronous UBC diagnosis in UTUC patients was an independent predictor of worse PFS (HR 3.326 CI 95% 1.474–7.503, p = 0.004), but it was not identified as a prognostic factor for OS (p > 0.05). Lymphovascular invasion (LVI) was associated with decreased PFS (HR 2.687 CI 95%1.172–6.163, p = 0.020) and OS (HR 4.980 CI 95%1.763–14.064, p = 0.002). This study indicates that concomitant or later UBC could predict a poor PFS, but it is not associated with a significantly worse OS in UTUC patients. The prognostic impact of LVI underlines its inclusion in the tumor staging system of UTUC.
Title: Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Description:
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial.
We evaluated the effect of the involvement of urothelial bladder carcinoma (UBC) as a potential prognostic factor for overall survival (OS) and progression-free survival (PFS).
The cohort included 115 patients with UTUC, subgrouped between January 2009 and December 2019 as follows: (1) only UTUC and (2) UTUC with synchronous or metachronous UBC (UTUC + UBC).
Univariate and multivariate analyses were performed to identify independent prognostic factors for OS and PFS.
Synchronous or metachronous UBC diagnosis in UTUC patients was an independent predictor of worse PFS (HR 3.
326 CI 95% 1.
474–7.
503, p = 0.
004), but it was not identified as a prognostic factor for OS (p > 0.
05).
Lymphovascular invasion (LVI) was associated with decreased PFS (HR 2.
687 CI 95%1.
172–6.
163, p = 0.
020) and OS (HR 4.
980 CI 95%1.
763–14.
064, p = 0.
002).
This study indicates that concomitant or later UBC could predict a poor PFS, but it is not associated with a significantly worse OS in UTUC patients.
The prognostic impact of LVI underlines its inclusion in the tumor staging system of UTUC.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
AbstractSolute carrier family 12 member 5 (SLC12A5) has an oncogenic role in bladder urothelial carcinoma. The present study aimed to characterize the molecular mechanisms of SLC12...
Epstein–Barr virus DNA load in tumour tissues correlates with poor differentiation status in non‐muscle invasive urothelial carcinomas
Epstein–Barr virus DNA load in tumour tissues correlates with poor differentiation status in non‐muscle invasive urothelial carcinomas
What’s known on the subject? and What does the study add?
Epstein‐Barr virus (EBV) could be detected in bladder cancer. In our paper, we sh...
SALL4 Expression in Urothelial Carcinoma of Urinary Bladder; aTissue Microarray Analysis
SALL4 Expression in Urothelial Carcinoma of Urinary Bladder; aTissue Microarray Analysis
Sal-like protein 4 (SALL4) is a cellular pluripotent embryonic nuclear factor that has been a useful immunohistochemistry marker for germ-cell tumors. Our understanding of SALL4 ex...
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up
Background:
Upper tract urothelial carcinoma (UTUC) is a malignant disease of the urothelial cell lining the upper urinary tract from renal calyces, pelvises, a...
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up
Background:
Upper tract urothelial carcinoma (UTUC) is a malignant disease of the urothelial cell lining the upper urinary tract from renal calyces, pelvises, a...
Urinary Bladder Cancer-Epidemiological and Histopathological Study
Urinary Bladder Cancer-Epidemiological and Histopathological Study
Urinary bladder cancer is the main reason for morbidity and mortality throughout the world. Urothelial carcinoma is a common primary tumor of urinary bladder (90%). To investigate ...

